3,933
Views
0
CrossRef citations to date
0
Altmetric
Review

Drug Repurposing Against SARS-CoV-1, SARS-CoV-2 and MERS-CoV

ORCID Icon, , , , , & ORCID Icon show all
Pages 1341-1370 | Received 21 Jan 2021, Accepted 08 Oct 2021, Published online: 10 Nov 2021
Supplemental material

List of druggable compounds for which a molecular docking study predicted an interaction with a viral protein of SARS-CoV-2.

Download MS Word (23.2 KB)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.